openPR Logo
Press release

Janssen Pharmaceutica teams up with GEA Pharma Systems to investigate continuous tablet manufacture to save time and money and to achieve consistent quality

10-10-2012 11:10 AM CET | Science & Education

Press release from: GEA Pharma Systems

/ PR Agency: The Words Workshop
Janssen Pharmaceutica, part of the worldwide Janssen Pharmaceutica Group, has initiated a global project with the aim of evaluating technical performance and related business benefits of continuous processing technologies for oral solid dosage forms. In this context, ConsiGma™ continuous processing technology from GEA Pharma Systems has been assessed for tablet manufacture. During an in-depth feasibility study at GEA Pharma Systems’ lab, the team from Janssen has been able to demonstrate the system’s benefits in relation to time, cost and agility.

The GEA equipment used in the study included a ConsiGma™ 25: a multi-purpose platform that, when combined with a Courtoy™ MODUL™ P rotary tablet press, processes powder into tablets in development, pilot, clinical and production volumes in a single compact unit. ConsiGma™ can produce granules continuously, with minimal waste during start-up and shut-down, while determining batch size only by the length of the run.

Online quality measurements were taken throughout the process facilitated by the GEA Lighthouse Probe™ that prevents product sticking to the observation windows of the process analyser.

The trial consisted of a series of test runs including one of ten hours, three repeat runs of five hours to prove repeatability and reproducibility, and finally a 16-hour run to assess the overall performance and online measuring techniques. The Critical Quality Attributes measured were moisture, particle size, blend uniformity and content uniformity. A Tandem system by Bruker Optics was used for the online measurement of the CQA’s of the tablets. The Siemens SIPAT® system was also selected as an advanced control system to gather and process all the data from the ConsiGma™ and the different online measurement devices.

The outcome of the trials led the Janssen team to conclude that the ConsiGma™ technology allows for process development in a very short time, for production cost reduction and for substantial time-to-market reduction. The agility of the system has allowed efficient and effective experiment design. The process stability and robustness was proven through the production of tablets of consistent quality.

Janssen believes that more intensive process monitoring and control will create a more stable and consistent process, faster development will lead to cost reductions, a smaller footprint to reduced investment, online monitoring and real-time release testing will reduce quality control costs, and the elimination of intermediate storage reduces inventory costs. As a result, obvious business value can be expected from this technology.


ConsiGma™ provides the maximum output while consuming less of the earth’s resources than any other system. It has been tested using over 100 different formulations and is already being used by several large pharmaceutical companies and research establishments worldwide.

GEA Pharma Systems is dedicated to innovation and thereby providing durable quality through its well-established brands: Aeromatic-Fielder™ and Collette™ - batch and continuous granulation, drying, pelletizing and coating; Buck® - contained materials handling; Courtoy™ - tablet compression; and Lyophil™ - pharmaceutical freeze drying.

All editorial enquiries to:
Steve Jordan
The Words Workshop Ltd
26 Swanwick Lane, Broughton, Milton Keynes, MK10 9LD
Tel: +44 1908 695500
Email: steve@thewordsworkshop.co.uk
Web: www.thewordsworkshop.co.uk

All business enquiries to:
Kris Schoeters
GEA Pharma Systems nv – Collette™
Keerbaan 70, B-2160 Wommelgem, Belgium
Tel: +32 3 350 12 88
Fax: +32 3 353 20 55
E-mail: kris.schoeters@geagroup.com
Web: www.geapharmasystems.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Janssen Pharmaceutica teams up with GEA Pharma Systems to investigate continuous tablet manufacture to save time and money and to achieve consistent quality here

News-ID: 237898 • Views:

More Releases from GEA Pharma Systems

GEA Pharma Systems presents European granulation, drying, tableting and fermenta …
GEA Pharma Systems will be exhibiting at CHINA-PHARM 2012 from 24 to 27 September at the China National Convention Center in Beijing. Exhibits on stand number 3017 will include examples of the company’s range of Aeromatic-Fielder™ and Collette™ granulation and drying plant; MODUL™ tablet presses from Courtoy™; and pharmaceutical fermentation systems from GEA Diessel showing state-of-the-art technology for a bioreactor vessel. On 25 September the company will present a
Combined pharmaceutical freeze drying service proves a success in China for GEA …
It was in November 2010 that GEA Pharma Systems acquired Beijing Sino-German Tianhe Technology in Beijing to create GEA Lyophil (Beijing) Ltd. Since then, the company has quadrupled turnover and enhanced its customer service by blending German quality and Chinese economy to provide a unique combined offering to its pharmaceutical clients. Jinbin Tang, MD, GEA Lyophil (Beijing) Ltd. said that the market had changed in China since the introduction of new
GEA Pharma Systems wins large order for continuous solid dose processing from major US pharmaceutical company
GEA Pharma Systems wins large order for continuous solid dose processing from ma …
GEA Pharma Systems has announced an agreement with a US pharmaceutical company to supply a complete continuous processing line for the production of solid dose drugs. The order is one of the more significant for ConsiGma™ oral solid dosage continuous processing equipment and represents the first phase of a potentially long-term commitment for this customer. Delivery is scheduled for early 2013. The order is to deliver a continuous solid
Leading contract manufacturer Penn Pharma in UK has chosen GEA Pharma Systems as key supplier to provide a fully integrated production line for contained development and production
Leading contract manufacturer Penn Pharma in UK has chosen GEA Pharma Systems as …
GEA Pharma Systems has secured a high value order for processing equipment with Penn Pharma based in Tredegar in South Wales. The new equipment will significantly increase the pharmaceutical contract manufacturer’s production capacity and allow it to provide a single source for high containment development and manufacture of highly potent drugs for its international customers. Penn Pharma believes that the new production plant will give it a leading position

All 5 Releases


More Releases for ConsiGma™

Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management …
Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management System into Therapoid™. Innovative manuscript development tool to be integrated into scientific collaboration platform. Minneapolis, MN and Boston, MA – June 27, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, and doDOC, a online collaborative writing tool that allows researchers to plan, draft, edit, review and approve professional documents more than 70% faster, have partnered. Therapoid™ will freely
MetaFix™ PlantarMAX™ Foot Plate received FDA-Release
Merete Medical GmbH announces the FDA-approval for MetaFix™ PlantarMAX™ plate. PlantarMAX™ is designed as the first plantar/medial Lapidus fixation plate which takes advantage of the biomechanically superior fixation on the tension side of the Metatarsal/Cuneiform joint during a Lapidus Hallux Valgus correction procedure. The fixation on the tension side of the joint is superior to dorsal or medial fixation and offers additional compression as the patient proceeds to weight bearing. Merete
Dali Wireless™ Introduces its Low Power t-Series Solution: tHost™ and t30™
Palo Alto, October 25, 2012 – Dali Wireless, a leader in next generation wireless infrastructure, today announced the release of its low power t-Series solution, which consists of the t30 remote unit and the tHost head-end. The exponential growth of mobile data capacity is challenging traditional cellular networks. Dali Wireless has created a unique solution to address these capacity limitations by combining industry standard protocols with the culmination of over
GFI™ Software Announces GFI LANguard™ 2011
Clearwater, FL – May 23, 2011 – GFI Software’s Infrastructure Business Unit today announced the launch of GFI LANguard™2011, the latest version of the company’s comprehensive network vulnerability scanning and patch management solution. GFI LANguard 2011 is the first network vulnerability and patch management solution to integrate with more than 1,500 security applications and to include keyword search functionality, illustrating GFI’s commitment to providing small and medium-sized businesses (SMBs) with
Pixelmetrix to launch Consolidator™, its new generation Network Management Sys …
Singapore – April 1, 2011 – Pixelmetrix, the global expert in Preventive Monitoring for digital television and IPTV networks, is set to launch Consolidator™, its new generation Network Management System, StationView™ for Simple, Effective Monitoring and the Electronic Couch Potato™ (ECP) Video Quality Index™ (VQI) for video quality verification. Consolidator™ provides centralized access and visibility of key network fault and performance information. Scalable to thousands of probes and millions of
SaferWatch™ announces TIN Manager™
HEBRON, ND – SaferWatch announces the release of their latest software solution, TIN Manager™. The TIN Manager feature is designed to verify the accuracy of Taxpayer Identification Number (TIN) and name information prior to submitting 1099’s to the IRS so that the company will not be penalized or fined for mismatches. TIN Manager eliminates tax preparation hassles by giving the bookkeeping departments of broker and shipper businesses a